ATA129892A - Pharmazeutische zusammensetzung - Google Patents

Pharmazeutische zusammensetzung

Info

Publication number
ATA129892A
ATA129892A AT0129892A AT129892A ATA129892A AT A129892 A ATA129892 A AT A129892A AT 0129892 A AT0129892 A AT 0129892A AT 129892 A AT129892 A AT 129892A AT A129892 A ATA129892 A AT A129892A
Authority
AT
Austria
Prior art keywords
pharmaceutical composition
pharmaceutical
composition
Prior art date
Application number
AT0129892A
Other languages
English (en)
Other versions
AT403436B (de
Original Assignee
Novartis Erfind Verwalt Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10697415&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATA129892(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Erfind Verwalt Gmbh filed Critical Novartis Erfind Verwalt Gmbh
Publication of ATA129892A publication Critical patent/ATA129892A/de
Application granted granted Critical
Publication of AT403436B publication Critical patent/AT403436B/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11C—FATTY ACIDS FROM FATS, OILS OR WAXES; CANDLES; FATS, OILS OR FATTY ACIDS BY CHEMICAL MODIFICATION OF FATS, OILS, OR FATTY ACIDS OBTAINED THEREFROM
    • C11C3/00—Fats, oils, or fatty acids by chemical modification of fats, oils, or fatty acids obtained therefrom
    • C11C3/04—Fats, oils, or fatty acids by chemical modification of fats, oils, or fatty acids obtained therefrom by esterification of fats or fatty oils
    • C11C3/06—Fats, oils, or fatty acids by chemical modification of fats, oils, or fatty acids obtained therefrom by esterification of fats or fatty oils with glycerol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nanotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biophysics (AREA)
  • Medical Informatics (AREA)
  • Communicable Diseases (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Transplantation (AREA)
  • Oncology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Fats And Perfumes (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Confectionery (AREA)
AT0129892A 1991-06-27 1992-06-25 Pharmazeutische zusammensetzung AT403436B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919113872A GB9113872D0 (en) 1991-06-27 1991-06-27 Improvements in or relating to organic compounds

Publications (2)

Publication Number Publication Date
ATA129892A true ATA129892A (de) 1997-07-15
AT403436B AT403436B (de) 1998-02-25

Family

ID=10697415

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0129892A AT403436B (de) 1991-06-27 1992-06-25 Pharmazeutische zusammensetzung

Country Status (38)

Country Link
EP (2) EP0953630B1 (de)
JP (2) JP2653958B2 (de)
KR (3) KR0131064B1 (de)
CN (1) CN1077798C (de)
AT (1) AT403436B (de)
AU (1) AU659460B2 (de)
CA (2) CA2175842C (de)
CH (2) CH684163A5 (de)
CY (1) CY1906A (de)
CZ (1) CZ281790B6 (de)
DE (3) DE4219526C2 (de)
DK (2) DK0539319T3 (de)
EE (1) EE03108B1 (de)
ES (2) ES2142818T3 (de)
FI (2) FI109454B (de)
FR (2) FR2678169B1 (de)
GB (2) GB9113872D0 (de)
GR (1) GR3032366T3 (de)
HK (2) HK57196A (de)
HU (1) HU216792B (de)
IE (1) IE73662B1 (de)
IL (3) IL118546A (de)
IT (1) IT1254401B (de)
LU (1) LU88138A1 (de)
MX (1) MX9203236A (de)
MY (1) MY109512A (de)
NO (2) NO303964B1 (de)
NZ (1) NZ243309A (de)
PH (1) PH30337A (de)
PT (2) PT539319E (de)
RO (2) RO111021B1 (de)
RU (1) RU2143919C1 (de)
SA (1) SA92130213B1 (de)
SK (1) SK278759B6 (de)
TW (1) TW267943B (de)
UA (1) UA35559C2 (de)
UY (1) UY23864A1 (de)
ZA (1) ZA924719B (de)

Families Citing this family (79)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9113872D0 (en) * 1991-06-27 1991-08-14 Sandoz Ag Improvements in or relating to organic compounds
EP0589843B1 (de) * 1992-09-25 2001-11-28 Novartis AG Cyclosporin enthaltende pharmazeutische Zusammensetzungen
NZ247516A (en) * 1993-04-28 1995-02-24 Bernard Charles Sherman Water dispersible pharmaceutical compositions comprising drug dissolved in solvent system comprising at least one alcohol and at least one surfactant
GB2278780B (en) * 1993-05-27 1998-10-14 Sandoz Ltd Macrolide formulations
AT408520B (de) * 1993-05-27 2001-12-27 Novartis Erfind Verwalt Gmbh Galenische formulierungen
CH686761A5 (de) 1993-05-27 1996-06-28 Sandoz Ag Galenische Formulierungen.
DE4322826A1 (de) * 1993-07-08 1995-01-12 Galenik Labor Freiburg Gmbh Pharmazeutisches Präparat
ES2152281T3 (es) * 1993-09-28 2001-02-01 Scherer Gmbh R P Fabricacion de capsulas de gelatina blanda.
DE4340781C3 (de) * 1993-11-30 2000-01-27 Novartis Ag Cyclosporin enthaltende flüssige Zubereitungen und Verfahren zu ihrer Herstellung
WO1995022343A1 (en) * 1994-02-17 1995-08-24 Shiseido Company, Ltd. Cyclosporin-containing emulsion composition
US5891846A (en) * 1994-02-17 1999-04-06 Shiseido Company, Ltd. Cyclosporin-containing emulsion composition
NZ270145A (en) * 1994-03-01 1996-08-27 Lilly Co Eli Non-aqueous pharmaceutical formulation for oral administration comprising water-insoluble active agent, fatty acid solubilising agent, an oil and a surface active agent
GB9405304D0 (en) * 1994-03-16 1994-04-27 Scherer Ltd R P Delivery systems for hydrophobic drugs
DE69510404T2 (de) * 1994-03-31 2000-01-20 Loders Croklaan B.V., Wormerveer Öle mit niedrigem Gehalt an gesättigter Fettsäure
PE52896A1 (es) 1994-10-26 1996-12-12 Novartis Ag Composicion farmaceutica
GB2308545B (en) * 1994-10-26 1999-06-02 Novartis Ag Pharmaceutical microemulsion preconcentrates
CZ287806B6 (en) 1994-11-03 2001-02-14 Novartis Ag Cyclosporin pharmaceutical preparation for oral administration and process of its preparation
HU215966B (hu) * 1994-11-21 1999-07-28 BIOGAL Gyógyszergyár Rt. Orálisan alkalmazható, ciklosporint tartalmazó, összetett emulzió-előkoncentrátum
EP0827402A2 (de) * 1995-05-17 1998-03-11 Cedars-Sinai Medical Center Fettsäure enthaltende zusammensetzungen zur verbesserung der verdauung und absorption des dünndarms
US6861053B1 (en) 1999-08-11 2005-03-01 Cedars-Sinai Medical Center Methods of diagnosing or treating irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth
WO1996036330A2 (en) * 1995-05-17 1996-11-21 Cedars-Sinai Medical Center Compositions containing fatty acids for improving digestion and absorption in the small intestine
US7048906B2 (en) 1995-05-17 2006-05-23 Cedars-Sinai Medical Center Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions
US6008228A (en) * 1995-06-06 1999-12-28 Hoffman-La Roche Inc. Pharmaceutical compositions containing proteinase inhibitors
US6696413B2 (en) * 1995-06-16 2004-02-24 Hexal Ag Pharmaceutical preparation with cyclosporin A
SE504582C2 (sv) * 1995-07-06 1997-03-10 Gs Dev Ab Cyklosporinkomposition baserad på en L2-fas
DE19549852B4 (de) * 1995-11-29 2009-06-04 Novartis Ag Cyclosporin enthaltende Präparate
US5858401A (en) 1996-01-22 1999-01-12 Sidmak Laboratories, Inc. Pharmaceutical composition for cyclosporines
CN1104258C (zh) * 1996-05-29 2003-04-02 周德和 用于环孢霉素a的赋形剂
DE69731072T2 (de) * 1996-06-19 2005-10-06 Novartis Ag Cyclosporin enthaltende weichkapselpräparate
US5958876A (en) * 1996-06-19 1999-09-28 Novartis Ag Cyclosporin-containing pharmaceutical compositions
KR980008239A (ko) * 1996-07-26 1998-04-30 김충환 사이클로스포린-함유 약학적 조성물
FR2752732B1 (fr) * 1996-08-28 1998-11-20 Pf Medicament Forme galenique a liberation prolongee de milnacipran
ZA9711732B (en) 1996-12-31 1998-12-28 Quadrant Holdings Cambridge Methods and compositions for improvement bioavailability of bioactive agents for mucosal delivery
TR199902199T2 (xx) * 1997-03-12 2002-06-21 Abbott Laboratories Siklosporin tatbiki i�in hidrofilik ikili sistemler.
US6258783B1 (en) 1997-04-29 2001-07-10 Bernard Charles Sherman Emulsion preconcentrate comprising a cyclosporin and acetylated monoglyceride
NZ314702A (en) * 1997-04-29 1998-07-28 Bernard Charles Sherman Pharmaceutical composition comprising a cyclosporin in a solvent system of acetylated monoglycerides and a surfactant and optionally a hydrophilic solvent
GB2326337A (en) 1997-06-20 1998-12-23 Phares Pharma Holland Homogeneous lipid compositions for drug delivery
RU2211021C2 (ru) * 1997-07-29 2003-08-27 Фармация Энд Апджон Компани Фармацевтическая самоэмульгирующая композиция и ее носитель для липофильных фармацевтически активных агентов
BR9810866B1 (pt) * 1997-07-29 2010-07-13 composição farmacêutica em uma forma de formulação auto-emulsificante para compostos lipofìlicos.
SI0989851T1 (en) 1997-07-29 2003-04-30 Pharmacia & Upjohn Company Self-emulsifying formulation for acidic lipophilic compounds
US20030220234A1 (en) 1998-11-02 2003-11-27 Selvaraj Naicker Deuterated cyclosporine analogs and their use as immunodulating agents
US6201165B1 (en) 1997-10-16 2001-03-13 Board Of Regents, University Of Texas System Transgenic animal models for cardiac hypertrophy and methods of use thereof
AU1508899A (en) * 1997-12-02 1999-06-16 Chong Kun Dang Corporation Pharmaceutical composition comprising cyclosporin solid-state microemulsion
KR100587551B1 (ko) 1997-12-10 2006-06-08 싸이클로스포린 테라퓨틱스 리미티드 오메가-3 지방산 오일을 함유하는 약학 조성물
ID25908A (id) * 1998-03-06 2000-11-09 Novartis Ag Prakonsentrat-prakonsentrat emulsi yang mengandung siklosporin atau makrolida
US6979456B1 (en) 1998-04-01 2005-12-27 Jagotec Ag Anticancer compositions
RU2178293C2 (ru) * 1998-08-18 2002-01-20 Панацея Биотек Лимитед Фармацевтическая композиция, содержащая циклоспорин, способ получения мягких желатиновых капсул
MXPA01005884A (es) * 1998-12-11 2002-04-24 Pharmasolutions Inc Composiciones auto-emulsionantes para medicamentos escasamente solubles en agua.
PT1154759E (pt) 1998-12-30 2008-11-20 Dexcel Ltd Concentrado dispersível para administração de ciclosporina
GB9903547D0 (en) 1999-02-16 1999-04-07 Novartis Ag Organic compounds
CN1167462C (zh) * 1999-03-09 2004-09-22 杭州华东医药集团生物工程研究所有限公司 一种含环孢素的药物组合物
US6956048B2 (en) 1999-03-31 2005-10-18 Pharmacia & Upjohn Company Pharmaceutical emulsions for retroviral protease inhibitors
AU2127400A (en) * 1999-11-02 2001-05-14 Cipla Limited A pharmaceutical composition for the administration of water-insoluble pharmaceutically active substances and process for preparation thereof
US7732404B2 (en) 1999-12-30 2010-06-08 Dexcel Ltd Pro-nanodispersion for the delivery of cyclosporin
GB0008785D0 (en) 2000-04-10 2000-05-31 Novartis Ag Organic compounds
GB0019118D0 (en) * 2000-08-03 2000-09-27 Danisco Solid phase glycerolysis
CN100421565C (zh) * 2000-08-08 2008-10-01 花王株式会社 油/脂组合物
US7115565B2 (en) 2001-01-18 2006-10-03 Pharmacia & Upjohn Company Chemotherapeutic microemulsion compositions of paclitaxel with improved oral bioavailability
AR033711A1 (es) * 2001-05-09 2004-01-07 Novartis Ag Composiciones farmaceuticas
JP2005506990A (ja) 2001-10-19 2005-03-10 アイソテクニカ インコーポレーテッド 新規のシクロスポリン類似体のマイクロエマルションプレコンセントレート
BRPI0213658A8 (pt) 2001-10-19 2016-12-06 F Hoffmann La Roche Ltd Método para preparar uma mistura isomérica predeterminada ou não dos análogos de ciclosporina a modificados no resíduo de 1-aminoácido, métodopara produzir uma mistura enriquecida com e-isômero ou com z-isômero de análogos de ciclosporina a modificados no resíduo de 1-aminoácido, mistura de (e) e (z)-isômeros, composição, método para a síntese estereoseletiva do z-isômero de isatx247, método para a preparação de aldeído do ciclosporina a
KR100441167B1 (ko) * 2001-12-27 2004-07-21 씨제이 주식회사 마이크로에멀젼 예비 농축액 조성물
KR100525234B1 (ko) * 2003-02-19 2005-10-28 한국유나이티드제약 주식회사 사이클로스포린 함유 연질캅셀제 및 그 제조방법
GT200500310A (es) * 2004-11-19 2006-06-19 Compuestos organicos
GB0504950D0 (en) 2005-03-10 2005-04-20 Novartis Ag Organic compositions
JP4889262B2 (ja) * 2005-08-19 2012-03-07 理研ビタミン株式会社 脂溶性薬剤組成物
MD3347G2 (ro) * 2006-12-26 2008-01-31 Институт Сельскохозяйственной Техники "Mecagro" Procedeu de obţinere a esterilor metilici din ulei de rapiţă
ITPD20070049A1 (it) * 2007-02-14 2008-08-15 Sila S R L Prodotto a base di acido linoleico coniugato e processo per la sua fabbricazione
ES2400964T3 (es) 2007-04-04 2013-04-15 Sigmoid Pharma Limited Composiciones famacéuticas de ciclosporina
CN101199836B (zh) * 2007-11-07 2011-03-30 安徽省药物研究所 一种阶段释放型环孢素a固体微乳制剂及其微乳固化方法
ES2649112T3 (es) 2009-05-18 2018-01-10 Sigmoid Pharma Limited Composición que comprende gotas de aceite
CA2770570A1 (en) 2009-08-12 2011-02-17 Sigmoid Pharma Limited Immunomodulatory compositions comprising a polymer matrix and an oil phase
GB201020032D0 (en) 2010-11-25 2011-01-12 Sigmoid Pharma Ltd Composition
JO3337B1 (ar) 2010-12-13 2019-03-13 Debiopharm Sa تركيبات صيدلية تشمل أليسبوريفير
FR2971941B1 (fr) 2011-02-24 2013-08-02 Physica Pharma Compositions pharmaceutiques administrables par voie cutanee et destinees au traitement local de la dermatite atopique canine
GB201304662D0 (en) 2013-03-14 2013-05-01 Sigmoid Pharma Ltd Compositions
SMT202100137T1 (it) 2014-11-07 2021-05-07 Sublimity Therapeutics Ltd Composizioni comprendenti la ciclosporina
JPWO2020050182A1 (ja) * 2018-09-06 2020-09-10 株式会社カマタ カプセル充填用液状組成物及びカプセル剤
US20200163876A1 (en) * 2018-11-26 2020-05-28 Hepion Pharmaceuticals, Inc. Pharmaceutical formulations of cyclosporine analogs

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1274354A (fr) * 1956-03-10 1961-10-27 Agents tensio-actifs obtenus à partir de triglycérides et polyéthylène glycol
FR2344283A1 (fr) * 1976-03-17 1977-10-14 Gattefosse Ets Sa Nouveau melange de glycerides utile comme nutriment lipidique
DE2907460A1 (de) * 1978-03-07 1979-09-13 Sandoz Ag Neue resorbierbare galenische kompositionen
CH641356A5 (en) * 1979-02-27 1984-02-29 Sandoz Ag Pharmaceutical compositions containing cyclosporin
PH19156A (en) * 1982-02-01 1986-01-15 Sandoz Ltd Dihydrocyclosporin d in the treatment of multiple sclerosis
GB8903804D0 (en) * 1989-02-20 1989-04-05 Sandoz Ltd Improvements in or relating to organic compounds
DE3444893A1 (de) * 1984-12-08 1986-06-12 Henkel KGaA, 4000 Düsseldorf Verfahren zur herstellung von fettsaeuremethylestern
JPS62201591A (ja) * 1986-02-28 1987-09-05 Shoichi Shimizu 油脂のグリセロリシス法
JP2632010B2 (ja) * 1988-01-29 1997-07-16 三共株式会社 シクロスポリン製剤
CH679119A5 (de) * 1988-05-13 1991-12-31 Sandoz Ag
HU201567B (en) * 1988-07-21 1990-11-28 Gyogyszerkutato Intezet Process for production of intravenous medical compositions containing cyclosphorin
GB2222770B (en) * 1988-09-16 1992-07-29 Sandoz Ltd Pharmaceutical compositions containing cyclosporins
GB8823621D0 (en) * 1988-10-07 1988-11-16 Madhok R Compositions containing cyclosporins
JPH0738771B2 (ja) * 1989-01-17 1995-05-01 花王株式会社 液状食用油組成物
FR2642650B1 (fr) * 1989-02-09 1994-12-09 Sandoz Sa Nouvelles compositions pharmaceutiques a base de cyclosporines
AU6785490A (en) * 1989-12-18 1991-06-20 Kraft General Foods, Inc. Low-saturate edible oils and transesterification methods for production thereof
GB9113872D0 (en) * 1991-06-27 1991-08-14 Sandoz Ag Improvements in or relating to organic compounds

Also Published As

Publication number Publication date
PT953630E (pt) 2004-11-30
SK278759B6 (sk) 1998-02-04
ES2227921T3 (es) 2005-04-01
LU88138A1 (fr) 1994-03-01
TW267943B (de) 1996-01-11
DE4219526C2 (de) 1999-04-22
IL102310A (en) 1997-03-18
NO922506L (no) 1992-12-28
MX9203236A (es) 1992-12-01
SA92130213B1 (ar) 2004-07-24
EP0953630B1 (de) 2004-09-08
NO922506D0 (no) 1992-06-25
GB2257359B (en) 1996-01-10
CA2072509C (en) 1996-07-30
KR0131064B1 (ko) 1998-04-17
EP0539319A2 (de) 1993-04-28
MY109512A (en) 1997-02-28
UA35559C2 (uk) 2001-04-16
CA2175842A1 (en) 1992-12-28
PH30337A (en) 1997-04-02
ZA924719B (en) 1993-12-27
CA2175842C (en) 2002-05-07
DK0539319T3 (da) 2000-05-22
HU216792B (hu) 1999-08-30
FR2678169A1 (fr) 1992-12-31
EP0539319B1 (de) 1999-12-08
HUT62201A (en) 1993-04-28
IL118546A (en) 1998-09-24
FI961513L (fi) 1996-04-03
FR2685706A1 (fr) 1993-07-02
FI961513A0 (fi) 1996-04-03
RO111021B1 (ro) 1996-06-28
ES2142818T3 (es) 2000-05-01
KR930000113A (ko) 1993-01-15
JP3420897B2 (ja) 2003-06-30
HU9201975D0 (en) 1992-09-28
GB9113872D0 (en) 1991-08-14
PT539319E (pt) 2000-05-31
SK197792A3 (en) 1994-03-09
CZ197792A3 (en) 1993-01-13
IE73662B1 (en) 1997-06-18
DE4244986B4 (de) 2008-07-24
CH685764A5 (de) 1995-09-29
KR100231384B1 (en) 1999-11-15
DE4219526A1 (de) 1993-03-18
HK157696A (en) 1996-08-30
AU659460B2 (en) 1995-05-18
NO964382L (no) 1992-12-28
JP2653958B2 (ja) 1997-09-17
EE03108B1 (et) 1998-08-17
IL102310A0 (en) 1993-01-14
CH684163A5 (de) 1994-07-29
NO303964B1 (no) 1998-10-05
HK57196A (en) 1996-04-12
CN1077798C (zh) 2002-01-16
EP0539319A3 (en) 1993-06-09
FI116199B (fi) 2005-10-14
IT1254401B (it) 1995-09-14
GB2257359A (en) 1993-01-13
FI922958L (fi) 1992-12-28
DK0953630T3 (da) 2004-11-01
RO111110B1 (ro) 1996-06-28
UY23864A1 (es) 1995-05-29
CY1906A (en) 1992-06-24
CA2072509A1 (en) 1992-12-28
RU2143919C1 (ru) 2000-01-10
IL118546A0 (en) 1996-10-16
FI109454B (fi) 2002-08-15
FR2685706B1 (de) 1994-12-23
FI922958A0 (fi) 1992-06-25
KR100231385B1 (en) 1999-11-15
EP0953630A1 (de) 1999-11-03
NO964382D0 (no) 1996-10-15
CZ281790B6 (cs) 1997-01-15
AT403436B (de) 1998-02-25
IE922082A1 (en) 1992-12-30
ITRM920476A0 (it) 1992-06-23
JPH09118894A (ja) 1997-05-06
AU1852792A (en) 1993-03-11
DE4244930C2 (de) 1999-11-11
JPH05186365A (ja) 1993-07-27
NZ243309A (en) 1995-02-24
FR2678169B1 (fr) 1994-08-26
GB9213393D0 (en) 1992-08-05
GR3032366T3 (en) 2000-04-27
ITRM920476A1 (it) 1993-12-23
CN1079907A (zh) 1993-12-29
NO325267B1 (no) 2008-03-17

Similar Documents

Publication Publication Date Title
ATA129892A (de) Pharmazeutische zusammensetzung
DE4291156T1 (de) Verbesserte pharmazeutische Zusammensetzungen
FI981777L (fi) Farmaseuttinen ainekoostumus
FI922316L (fi) Farmaceutisk sammansaettning
ATE203400T1 (de) Pharmazeutische formulierungen
DE10199066I1 (de) Pharmazeutische Zusammensetzung
DE69101931D1 (de) Pharmazeutische Zusammensetzung.
NO923127L (no) Farmasoeytisk kombinasjonsformulering
FI923582L (fi) Farmaceutisk sferoidkomposition
FI925661L (fi) Injicerbar farmaceutisk komposition
DE69115263D1 (de) Pharmazeutische zusammensetzungen.
FI924456A7 (fi) Lääke
DE69006094D1 (de) Pharmazeutische Zusammensetzungen.
BR9200058A (pt) Composto e composicao farmaceutica
MX9200622A (es) Composicion farmaceutica
DE4294862T1 (de) Pharmazeutische Komposition
DE69434210D1 (de) Pharmazeutische antacidzusammensetzung
UA26064A1 (uk) Фармацевтичhа композиція
FI921786A7 (fi) Farmaceutisk foerening
FI921785A7 (fi) Farmaceutisk foerening
FI934387A0 (fi) 3-substituerade 2-oxi-indol-1-karboxiamid omfattande farmaceutiska kompositioner
FI923869L (fi) Farmaceutiska aemnen
DE69003003D1 (de) Pharmazeutische Zusammensetzung.
SE9103213D0 (sv) Farmaceutisk komposition
SE9101348D0 (sv) Pharmaceutical composition

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
MK07 Expiry

Effective date: 20120625